The Role of the Pharmacist in Mental Health
DOI:
https://doi.org/10.55892/jrg.v7i15.1648Keywords:
Mental health, Public health, Psychotropic drugs, Pharmaceutical AssistanceAbstract
Mental disorders, such as anxiety and depression, have a high prevalence and are increasing worldwide. Against this backdrop, pharmacists are ideally positioned to play a greater role in supporting people with mental illness. This study seeks to analyze the role of the pharmacist in the patient's mental health. The methodology is a bibliographic review guided by theoretical references. Queries and searches of articles were carried out in the following databases: PubMed, SciELO, VHL and Google Scholar. The results highlight that the role of pharmacists is crucial to improve adherence to treatments and clinical outcomes, also highlighting the importance of their integration into mental health teams. The study concluded that appreciation, continuous training and appreciation policies are crucial to optimize the contribution of pharmacists in mental health care.
Downloads
References
ALJUMAH, K.; HASSALI, M. A. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC psychiatry, v. 15, p. 1-9, 2015.Disponível em:https://link.springer.com/article/10.1186/s12888-015-0605-8. Acessoem: 04 de set. 2024.
CHONG, Wei Wen; ASLANI, Parisa; CHEN, Timothy F. Adherence to antidepressant medications: an evaluation of community pharmacists’ counseling practices. Patientpreferenceandadherence, p. 813-825, 2013.Disponível em: https://www.tandfonline.com/doi/abs/10.2147/PPA.S48486. Acesso em: 02 de set. 2024.
COSTA-OLIVEIRA, Claudete da et al. Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis. Pharmacy, v. 12, n. 4, p. 100, 2023.Disponível em:https://www.mdpi.com/2226-4787/12/4/100. Acessoem: 04 de set. 2024.
CROFT, Harry A. et al. Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, v. 75, n. 11, p. 6228, 2014.Disponívelem: https://www.psychiatrist.com/jcp/efficacy-safety-vilazodone-major-depressive-disorder/. Acessoem: 04 de set. 2024.
EL-DEN, Sariraet al. Pharmacists’ roles in supporting people living with severe and persistent mental illness: a systematic review protocol. BMJ open, v. 10, n. 7, p. e038270, 2020.Disponível em:https://bmjopen.bmj.com/content/10/7/e038270.abstract. Acesso em: 04 de set. 2024.
FAQUIH, Amber E. et al. A review of novel antidepressants: a guide for clinicians. Cureus, v. 11, n. 3, 2019. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504013/. Acesso em: 03 de ago. 2024.
FERNANDES, Sheilla Alessandra Ferreira et al. Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?Journalof Young Pharmacists, v. 12, n. 4, p. 373, 2020. Disponível em: https://www.jyoungpharm.org/sites/default/files/tmp/JYoungPharm-12-4-373.pdf. Acesso em: 20 de ago. 2024.
HUANG, Fei; WU, Xiaojun. Brain neurotransmitter modulation by gut microbiota in anxiety and depression. Frontiers in cell and developmental biology, v. 9, p. 649103, 2021. Disponívelem: https://www.frontiersin.org/articles/10.3389/fcell.2021.649103/full?ref=tomecontroldesusalud.com. Acessoem: 04 de set. 2024.
ILICKOVIC, Ivana M. et al. Pharmaceutical care in a long-stay psychiatric hospital. EuropeanJournalof Hospital Pharmacy, v. 23, n. 3, p. 177-181, 2016.Disponível em: https://ejhp.bmj.com/content/23/3/177.short. Acesso em: 14 de ago. 2024.
LIMA, DéborahKarollyne Ribeiro Ramos; GUIMARÃES, Jacileide. Articulação da Rede de Atenção Psicossocial e continuidade do cuidado em território: problematizando possíveis relações. Physis: Revista de Saúde Coletiva, v. 29, p. e290310, 2019. Disponível em:https://www.scielo.br/j/physis/a/46y3mHF9kdx7DHQGHwpspdf/. Acessoem: 14 de ago. 2024.
LOSADA-CAMACHO, Martha et al. Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study). Health and quality of life outcomes, v. 12, p. 1-11, 2014.Disponível em:https://link.springer.com/article/10.1186/s12955-014-0162-8. Acessoem: 04 de ago. 2024.
MARCHIONATTI, LauroEstivaleteet al. Mental health care delivery and quality of service provision in Brazil. SSM-Mental Health, v. 3, p. 100210, 2023.Disponível em:https://www.sciencedirect.com/science/article/pii/S2666560323000257. Acesso em: 04 de set. 2024.
MARTINS, Ana Cláudia Magnus et al. Protocolos de regulação ambulatorial: psiquiatria adulto. 2021.Disponível em: https://lume.ufrgs.br/bitstream/handle/10183/266068/001186028.pdf?sequence=1. Acesso em: 03 de ago. 2024.
MENDES, Eugênio Vilaça. 25 anos do Sistema Único de Saúde: resultados e desafios. Estudos avançados, v. 27, p. 27-34, 2013. Disponível em:https://www.scielo.br/j/ea/a/gzYFsDyxzXPjJK8WvWvG8th/?lang=pt. Acessoem: 04 de set. 2024.
MOHIUDDIN, Abdul Kader. Psychiatric pharmacy: new role of pharmacists in mental health. J Psychiatry Mental Disord, v. 4, n. 1, p. 1010, 2019. Disponível em:https://www.sarpublication.com/media/articles/SARJPS_11_6-10_c.pdf. Acesso em: 04 de set. 2024.
MOHIUDDIN, Abdul Kader. Psychiatric pharmacy: new role of pharmacists in mental health. J Psychiatry Mental Disord, v. 4, n. 1, p. 1010, 2019. Disponível em: https://www.sarpublication.com/media/articles/SARJPS_11_6-10_c.pdf. Acessoem: 03 de ago. 2024.
MONTGOMERY, Stuart A. et al. A randomised, double‐blind study in adults with major depressive disorder with an inadequate response-to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. HumanPsychopharmacology: Clinicaland Experimental, v. 29, n. 5, p. 470-482, 2014. Disponível em:https://onlinelibrary.wiley.com/doi/abs/10.1002/hup.2424. Acesso em: 04 de ago. 2024.
MURPHY, Andrea L. et al. Community pharmacists’ experiences in mental illness and addictions care: a qualitative study. Substance abuse treatment, prevention, and policy, v. 11, p. 1-14, 2016. Disponívelem:https://link.springer.com/article/10.1186/s13011-016-0050-9. Acesso em: 14 de ago. 2024.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. FactSheetsof Mental Disorders; Organização Mundial da Saúde: Genebra, Suíça, 2022; Disponível: https://www.who.int/news-room/fact-sheets/detail/mental-disorders. Acesso em: 14 de ago. 2024.
ORGANIZAÇÃO MUNDIAL DE SAÚDE. OMS. Saúde Mental. 2022. Disponível em: https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response. Acesso em:03 de ago. 2024.
PAIM, Jairnilson Silva. Os sistemas universais de saúde e o futuro do Sistema Único de Saúde (SUS). Saúde em debate, v. 43, p. 15-28, 2020.Disponível em:https://www.scielo.br/j/sdeb/a/L9yVS4pjsxkShgZqk3z6Y4r/?format=html&lang=pt. Acesso em: 01 de set. 2024.
PAIM, Jairnilson Silva; DE ALMEIDA FILHO, Naomar. Saúde coletiva: teoria e prática. MedBook, 2023. Disponível em: https://books.google.com.br/books?hl=pt-BR&lr=&id=KsanEAAAQBAJ&oi=fnd&pg=PT22&dq=Apesar+do+crescente+reconhecimento+de+que+os+profissionais+de+sa%C3%BAde+desempenham+um+papel+importante+na+identifica%C3%A7%C3%A3o,+suporte+e+gerenciamento+de+transtornos+mentais%3B+a+contribui%C3%A7%C3%A3o+cl%C3%ADnica+dos+farmac%C3%AAuticos+ainda+n%C3%A3o+foi+universalmente+aceita+ou+definida+de+forma+abrangente&ots=gm-MEFDMAo&sig=sxl6du8DcRi9lp5xnLf7Rv2WYs4. Acesso em:01 de set. 2024.
RICHARDSON, Tom E.; O’REILLY, Claire L.; CHEN, Timothy F. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Internationaljournalofclinicalpharmacy, v. 36, p. 222-232, 2014.Disponível em: https://www.sciencedirect.com/science/article/pii/S2666560323000257. Acesso em: 01 de set. 2024.
RUBIO-VALERA, Maria; CHEN, Timothy F.; O’REILLY, Claire L. New roles for pharmacists in community mental health care: a narrative review. International journal of environmental research and public health, v. 11, n. 10, p. 10967-10990, 2014. Disponível em: https://www.mdpi.com/1660-4601/11/10/10967. Acesso em:03 de set. 2024.
SHARAFI, AmirMohammadet al. Rapid treatments for depression: endocannabinoid system as a therapeutic target. Neuroscience&BiobehavioralReviews, v. 137, p. 104635, 2022.Disponível em:https://www.sciencedirect.com/science/article/pii/S0149763422001245. Acesso em: 04 de set. 2024.
SILVA, Sarah Nascimento; LIMA, Marina Guimarães. Assistência Farmacêutica na Saúde Mental: um diagnóstico dos Centros de Atenção Psicossocial. Ciência & Saúde Coletiva, v. 22, p. 2025-2036, 2017.Disponível em:https://www.scielo.br/j/csc/a/Y6ddvDrRBkBQS9mZdQZV5zB/. Acesso em: 04 de set. 2024.
SILVA, Sarah Nascimento; LIMA, Marina Guimarães; RUAS, Cristina Mariano. Intervenções farmacêuticas em saúde mental: Uma revisão da literatura para apoiar a formulação de políticas baseadas em evidências. Pesquisa em Farmácia Social e Administrativa,v. 14, n. 10, p. 891-900, 2018.Disponível em:https://www.sciencedirect.com/science/article/pii/S155174111730894X. Acessoem: 04 de set. 2024.
TAKEDA, Masatoshi et al. Is depression a somatic disease or a psychiatric disorder?Cognition & rehabilitation, v. 3, n. 1, p. 59-70, 2022. Disponível em:https://kawasakigakuen.repo.nii.ac.jp/?action=pages_view_main&active_action=repository_view_main_item_detail&item_id=376&item_no=1&page_id=13&block_id=21. Acesso em: 04 de set. 2024.
TRAPÉ, Thiago Lavras; CAMPOS, Rosana Onocko. Modelo de atenção à saúde mental do Brasil: análise do financiamento, governança e mecanismos de avaliação. Revista de Saúde Pública, v. 51, 2017. Disponível em:https://www.scielo.br/j/rsp/a/3sXhdXkTM7m47WTDHBLFPyS/?lang=pt. Acesso em: 04 de set. 2024.
